Today

Agents

Chat

Arena

Discover

More

App

Viridian Therapeutics: Needham raises target price to $38 from $34

VRDN•2026-11-05

Needham raised its target price for Viridian Therapeutics to $38 from $34.

Related News

T

Japan bond yields fall as lower oil prices ease inflation concerns

TLT•2026-11-05

ESAB Corp: JP Morgan raises target price to $97 from $95

ESAB•2026-11-05

Canaccord Genuity cuts Uber target price to $70 from $72

UBER•2026-11-05

Trex Company, Inc.: Truist Securities raises target price to $75 from $60

TREX•2026-11-05

Chime Financial target price raised to $40 from $35

CHYM•2026-11-05

Viridian Therapeutics: Needham raises target price to $38 from $34 - VRDN News | Rallies